Milestone Scientific (MLSS) Gains from Sales and Divestitures (2022 - 2026)

Milestone Scientific has disclosed Gains from Sales and Divestitures across 5 years of filings, most recently posting $170455.0 for Q1 2026.

• Gains from Sales and Divestitures for Q1 2026 came in at $170455.0, down 6.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $170455.0 (down 6.64% YoY), and the FY2025 annual result was $1.7 million, up 141.02% from the prior year.
• Gains from Sales and Divestitures came in at $170455.0 for Q1 2026 at Milestone Scientific, down from $1.7 million in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $1.7 million in Q4 2025 to a low of $170455.0 in Q1 2026.
• The 5-year median for Gains from Sales and Divestitures is $337081.0 (2025), against an average of $454371.9.
• Across the five-year window, Gains from Sales and Divestitures tumbled 39.29% in 2024 and jumped 141.02% in 2025, its largest moves.
• Milestone Scientific's Gains from Sales and Divestitures stood at $449695.0 in 2022, then surged by 54.47% to $694658.0 in 2023, then fell by 0.22% to $693106.0 in 2024, then surged by 141.02% to $1.7 million in 2025, then tumbled by 89.8% to $170455.0 in 2026.
• The last three Gains from Sales and Divestitures figures came in at $170455.0 (Q1 2026), $1.7 million (Q4 2025), and $337081.0 (Q3 2025), per Business Quant data.